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Abstract CASK, a member of the membrane-associated
guanylate kinase (MAGUK) superfamily, binds to the carbox-
yl-terminus of L-neurexins on the intracellular side of the
presynaptic membrane. The guanylate kinase-like (GUK)
domains of MAGUKs lack kinase activities, but might be
important for mediating specific protein^protein interaction. By
a yeast two-hybrid approach, we identified an interaction
between the GUK domain of CASK and the C2B domain of
rabphilin3a, a presynaptic protein involved in synaptic vesicle
exocytosis. The interaction was confirmed by in vitro GST pull-
down and co-immunoprecipitation assays. It was proposed that
presynaptic vesicles might be guided to the vicinity of points of
exocytosis defined by L-neurexins via the interaction between
rabphilin3a^CASK^L-neurexins. ß 2001 Federation of Euro-
pean Biochemical Societies. Published by Elsevier Science B.V.
All rights reserved.
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1. Introduction
The membrane-associated guanylate kinases (MAGUKs)
are a family of proteins that act as molecular sca¡olds for
signaling pathway components at the plasma membrane of
animal cells. MAGUK proteins share a multidomain organi-
zation including one or three postsynaptic density (PSD)-95/
SAP90 (PDZ) (Psd-Dlg-Zo1) domains, an Src homology 3
(SH3) domain, and a guanylate kinase-like (GUK) domain
[1,2]. CASK, an important member of the MAGUK super-
family, was originally identi¢ed as a binding partner of L-
neurexins located at the intracellular side of the presynaptic
membrane [3]. CASK is composed of an N-terminal Ca2/
calmodulin-dependent kinase-like domain, followed by a
PDZ domain, an SH3 domain, and a C-terminal domain ho-
mologous to guanylate kinase [3]. In neuronal systems, CASK
is allocated to the intracellular side of presynaptic membrane
by binding to the cytoplasmatic carboxyl-terminus of L-neu-
rexins. At synapse, CASK forms an asymmetric intercellular
junction with the postsynaptic PSD-95^neuroligin complex,
via the interaction between L-neurexins and neuroligins [4,5].
The N-terminal Ca2/calmodulin-dependent kinase-like do-
main of CASK interacts with Mint-1 [4] independent of the
association of Ca2/calmodulin with CASK; and Mint-1 in
turn binds to the tra⁄cking protein Munc-18 [6] which is
essential for exocytosis [7]. The Ca2/calmodulin-dependent
kinase-like domain of CASK also binds to Veli-1, which
may interact with receptor tyrosine kinases and other compo-
nents via its PDZ domain. Thus, CASK, Mint-1 and Veli-1
form a speci¢c salt-resistant complex functioning as a protein
sca¡old in the presynapses of neuronal cell terminals [4].
CASK is ubiquitously expressed, though highly enriched in
the brain [3,8]. In the basolateral membranes of epithelial
cells, the PDZ domain of CASK interacts with the cytoplas-
matic carboxyl-terminus of syndecan-2 [9]. A region between
the SH3 and GUK domains interacts with protein 4.1, which
associates with the actin cytoskeleton via spectrin and is thus
connected to the cytoskeletal system of the cell [8,9].
The GUK domains of MAGUKs lack enzymatic activity
and may be involved in protein^protein interactions [4]. For
example, the GUK domain of PSD-95 binds to guanylate ki-
nase domain-associated protein (GKAP) in postsynaptic
structures [10]. It was recently reported that the GUK domain
of CASK could bind to Tbr-1, a transcription regulator, di-
rectly enter the nucleus, and thereby regulate gene expression.
Thus, in contrast to the classical pathway, CASK and Tbr-1
may mediate a novel signal transduction pathway [11,12].
Here we report that in addition to Tbr-1, rabphilin3a, a pre-
synaptic protein involved in synaptic vesicle exocytosis, was
identi¢ed as the binding partner of the GUK domain of
CASK using yeast two-hybrid screening. Glutathione S-trans-
ferase (GST) pull-down and co-immunoprecipitation assays
con¢rmed the interaction. Possible roles of the rabphilin3a^
CASK^L-neurexins interaction in the exocytosis of presynap-
tic vesicles are discussed.
2. Materials and methods
2.1. Plasmid construction and protein expression
PLexA/GUK was constructed by inserting the GUK domain of
human CASK (GenBank GI: 2661105; SwissProt GI: 6166125), en-
coding amino acids 701^897, into pLexA (Clontech). The same GUK
domain of CASK was expressed using pGEX-2T (Amersham Phar-
macia Biotech) and pCDNA3.1(3)/myc-hisA (Invitrogen) in Escheri-
chia coli strain BL21(DE3) and COS-7 cells, respectively. Human
rabphilin3a gene, without N-terminal 415 amino acids, fused to a
myc tag (EQKLISEEDL) was cloned into pT7his (kindly provided
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by Dr. C. Fang). Human full-length rabphilin3a (GenBank GI:
4589613) and human rabphilin3a without C-terminal sequence encod-
ing the last 121 amino acids were inserted into pCDNA3 (Invitrogen)
fused with a FLAG epitope (DYKDDDDK) tag to generate
pCDNA3/rabphilin3a^FLAG and pCDNA3/rabphilin3a^v-C-FLAG
plasmids, respectively. All constructions were con¢rmed by sequenc-
ing. For protein expression in E. coli strain BL21(DE3), pGEX-2T- or
pT7his-based plasmids were induced using 0.1 mM isopropyl-L-D-
thiogalactoside (IPTG) at 30‡C for 3 h and analyzed by sodium
dodecyl sulfate^polyacrylamide gel electrophoresis (SDS^PAGE).
2.2. Yeast two-hybrid screening
A cDNA fragment encoding the human CASK/GUK domain (ami-
no acids 701^897) was used as bait to screen a human adult brain
cDNA library in pB42AD vector (Clontech). Approximately 2U106
yeast transformants were screened following the manufacturer’s in-
structions.
2.3. GST pull-down assay
The recombinant proteins of the bacterial pellet from a 1.5 ml
culture were solubilized in 250 Wl bu¡er 1 (50 mM Tris^Cl, pH 8.0,
150 mM NaCl, 1% Nonidet P-40, 50 Wg/ml soybean trypsin inhibitor,
10 Wg/ml leupeptin and 40 Wg/ml phenylmethylsulfonyl £uoride), and
sonicated. 50 Wl of each of the extract was mixed with 20 Wl of glu-
tathione-Sepharose 4B beads (Amersham Pharmacia Biotech) and
100 Wl bu¡er 2 added (50 mM Tris^Cl, pH 8.0, 150 mM NaCl,
0.1% Nonidet P-40, 50 Wg/ml soybean trypsin inhibitor, 10 Wg/ml
leupeptin and 40 Wg/ml phenylmethylsulfonyl £uoride). The reaction
was incubated for 1 h at room temperature with an end-over-end
shaking. The beads were separated by a brief centrifugation, washed
¢ve times with bu¡er 2, and suspended in 25 Wl sample-loading bu¡er
(50 mM Tris^Cl, pH 6.8, 100 mM DTT, 2% SDS, 0.1% bromophenol
blue, 10% glycerol). The bound proteins were analyzed by Western
blot using an anti-myc antibody (Calbiochem).
2.4. Cell culture, transient transfection, co-immunoprecipitation and
Western blot analysis
COS-7 cells were cultured in Dulbecco’s modi¢ed Eagle’s medium
containing 10% fetal bovine serum. Transient co-transfection of COS-
7 cells with pCDNA3/rabphilin3a^FLAG and pCDNA3.1(3)/myc-
hisA/GUK plasmids was performed for 3.5 h with the Lipofectamine
plus reagent (Gibco) following the manufacturer’s instructions.
pCDNA3/rabphilin3a^v-C-FLAG plasmid was used as control. Cells
were harvested 48 h after transfection and lysed in 20 mM Tris^Cl pH
8.0, 150 mM NaCl, 0.5% NP-40, 1 mM Na2VO4, 1 mM NaF, 1 mM
PMSF, 10 Wg/mg aprotinin, 10 Wg/ml pepstatin and 10 Wg/ml leupep-
tin. Nuclear and cellular debris was removed by centrifugation
at 10 000Ug for 15 min at 4‡C. Cell extracts were incubated with
2 Wg/ml of mouse anti-myc antibody (Calbiochem) overnight at 4‡C.
Protein A-agarose beads (Amersham Pharmacia Biotech) were then
added and incubated for 2 h at room temperature. The immunopre-
cipitated samples were washed extensively with lysis bu¡er and then
boiled in SDS-loading bu¡er. The supernatant was subjected to 12%
SDS^PAGE. The membrane was immunoblotted with chicken anti-
FLAG antibody and horseradish peroxidase-conjugated goat anti-
chicken IgY (Aves Labs). Bond antibodies were detected using the
ECL system (Amersham Pharmacia Biotech).
SDS^PAGE was performed in 12% polyacrylamide gels. Reduction
was achieved by boiling the samples for 5 min in sample-loading
bu¡er (see above). The gel was stained with Coomassie brilliant
blue R250. For Western blot analysis, the proteins were transferred
to nitrocellulose membrane (Schleicher and Schuell) at 0.65 mA/cm2
for 2 h in transfer bu¡er (48 mM Tris, 39 mM glycine, 0.037% SDS,
20% methanol). The membrane was blocked for 1 h in PBST (0.1%
Tween-20) containing 1% BSA and 4% milk, and incubated with 2 Wg/
ml mouse anti-myc antibody (Calbiochem) or 10 Wg/ml chicken anti-
FLAG antibody (Aves Labs) in PBST for 1 h and washed 3U10 min
with PBST. The membrane was then incubated with horseradish per-
oxidase-conjugated goat anti-mouse IgG (Amersham Pharmacia Bio-
tech) or horseradish peroxidase-conjugated goat anti-chicken IgY
(Aves Labs) for 1 h and washed as described before. Detection
made use of the enhanced chemiluminescence reaction (ECL, Amer-
sham Pharmacia Biotech), followed by exposition to X-ray ¢lm.
3. Results
To identify proteins binding to the GUK domain of CASK,
we screened a human adult brain cDNA library in a yeast
two-hybrid assay using the C-terminal GUK domain of
CASK as a bait. Screening of 2U106 yeast transformants
was carried out in selective medium and plasmid DNA of
the stronger interactions, which were able to grow in selective
media and displayed a strong L-galactosidase signal, were iso-
lated. Two kinds of clones encoding Tbr-1 and rabphilin3a
were obtained. The C-terminal fragment of Tbr-1 protein (res-
idues 398^681) was identi¢ed in the screening, consistent with
a recent report that the amino acids 342^681 of Tbr-1 are
necessary and su⁄cient for binding to the GUK domain of
CASK [11].
The rabphilin3a cDNA encoded the C-terminal 573^694
amino acid residues of the protein. Rabphilin3a was originally
identi¢ed as an upstream e¡ector of rab3a [13]. It contains an
N-terminal rab3a binding domain with a conserved Zn2 ¢n-
ger motif, a central domain with phosphorylation sites recog-
nizable by protein kinase A and Ca2/calmodulin-dependent
protein kinase II, and two C-terminal C2 domains (C2A and
C2B) which mediate protein^lipid or protein^protein interac-
tions [13^15]. It binds to rab3a in a GTP-dependent manner,
Fig. 1. Con¢rmation of yeast two-hybrid screening. A: GST pull-down assay of CASK and rabphilin3a. Bacterially expressed GST-GUK
fusion protein was bound to truncated rabphilin3a recombinant proteins in vitro. GST protein was used as control. Anti-myc antibody was
used to test the presence of rabphilin3a pulled down. Input: Bacterial expressed truncated rabphilin3a protein with a myc tag. Bound: Bound
proteins eluted from the glutathione-Sepharose beads. Salt wash: Wash bu¡er used to remove unbound proteins. B: Co-immunoprecipitation
of CASK-GUK-Myc with rabphilin3a^FLAG. Cell lysates from COS-7 cells co-transfected with pCDNA3.1(3)/myc-hisA/GUK and pCDNA3/
rabphilin3a^FLAG or pCDNA3/rabphilin3a^v-C-FLAG were immunoprecipitates using anti-FLAG antibody. Input: Cell extracts from the
COS-7 cells expressing recombinant rabphilin3a protein. Bound: Immunoprecipitates from COS-7 cells co-transfected with pCDNA3.1(3)/myc-
hisA/GUK and pCDNA3/rabphilin3a^FLAG. Truncated: Immunoprecipitates from COS-7 cells co-transfected with pCDNA3.1(3)/myc-hisA/
GUK and pCDNA3/rabphilin3a^v-C-FLAG. Salt wash: Wash bu¡er used to remove unbound proteins.
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and regulates synaptic vesicle exocytosis [16,17]. The cDNA
clone we obtained encoded only the C2B domain. Since both
CASK and rabphilin3a were reported to be predominantly
localized at the presynaptic active zone [18], we focussed our
attention on the interaction between CASK and rabphilin3a.
A GST pull-down assay was employed to independently
con¢rm the rabphilin3a^CASK interaction identi¢ed in the
yeast two-hybrid screening. The GUK domain (residues
701^897) of CASK fusing to the C-terminal of a bacterial
GST, and the C2 domains of rabphilin3a protein (residues
416^694) fused myc epitope in its C-terminal were expressed
in E. coli strain BL21(DE3). Fusion proteins were 48 and
34 kDa in molecular weight, respectively. To test the speci¢c-
ity of the binding, GST protein was used as a control. The
mixtures of GST-GUK with rabphilin3a-C2, and GST with
rabphilin3a-C2 recombinant proteins were incubated with glu-
tathione-Sepharose 4B beads. Proteins bound to the GST fu-
sion proteins were eluted and analyzed by Western blot using
anti-myc antibody. The Western blot results indicated that the
C2 domains of rabphilin3a protein bound to the GST-GUK
fusion protein. No interaction with C2 domains of rabphilin3a
was detectable for GST alone, con¢rming the speci¢city of the
GST-GUK^rabphilin3a-C2 interaction (Fig. 1A).
The interaction between rabphilin3a and CASK was also
con¢rmed by using the immunoprecipitation approach.
FLAG-tagged rabphilin3a and myc-tagged GUK domain
of CASK were expressed by transient transfection of
pCDNA3.1(3)/myc-hisA/GUK and pCDNA3/rabphilin3a^
FLAG plasmids in COS-7 cells. Truncated rabphilin3a pro-
tein without C-terminal 121 amino acids was used as a con-
trol. Binding of the expressed proteins was determined by co-
immunoprecipitation. Anti-myc antibody and protein A-aga-
rose were used to precipitate the truncated CASK protein.
The rabphilin3a^FLAG protein was detected in the precipi-
tate using an anti-FLAG antibody whereas the rabphilin3a
without C-terminal 121 amino acids was not (Fig. 1B). The
co-immunoprecipitation experiment was therefore consistent
with the result of the in vitro interaction between CASK
and rabphilin3a.
4. Discussion
The MAGUK superfamily constitutes a class of sca¡olding
proteins that recruit signaling molecules into localized multi-
molecular complexes. All MAGUK proteins contain PDZ and
SH3 domains, which mediate speci¢c protein^protein interac-
tions and form sca¡olds for protein networks at cell mem-
branes [1]. The GUK domains of MAGUK proteins lack
enzymatic activity, and might be responsible for protein^pro-
tein interactions as suggested by the fact that GKAP binds the
GUK domain of PSD-95 [10]. Interaction between the GUK
domain of CASK and Tbr-1 has been previously reported
[11]. Here we report that in addition to Tbr-1, rabphilin3a,
a presynaptic protein could bind to the same region of the
CASK protein. The C2B domain of rabphilin3a mediates the
interaction.
Rabphilin3a was the ¢rst identi¢ed rab3a e¡ector [13] bind-
ing to rab3a through its N-terminus [19]. Rab3a is a member
of a large family of low molecular weight GTPases that is
localized to synaptic vesicles, and is thought to mediate direc-
tional vesicular tra⁄cking and regulate synaptic vesicle exo-
cytosis. Rab3a cycles between an active, GTP-bound form
and an inactive, GDP-bound form, which is dependent
upon the accumulation of rabphilin3a which stabilizes the
GTP-bound form of rab3a on the vesicle [11,20].
The speci¢c interaction between CASK and raphilin3a
raised an interesting possibility that the sca¡olding proteins
might be involved in synaptic vesicle exocytosis at presynaptic
terminal. CASK, Mint-1, and Veli-1 form a tight, salt-resis-
tant sca¡olding protein complex at the presynaptic terminal,
and serve as a nucleus for the recruitment of channels and
receptors to L-neurexin/neuroligin junction at synapses [4]. A
previous report suggests that Mint-1 binds to the cytosolic
carboxyl-terminus of the K1B subunit of the N-type Ca2
channel, and that the SH3 domain of CASK might bind to
the proline-rich region of the same K1B subunit [21]. In addi-
tion, the N-terminus of Mint-1 could bind to Munc-18 [22], a
neuronal protein essential for synaptic vesicle exocytosis
[23,24], and thus mediate the recruitment of Munc-18 to neu-
rexins [25]. Our observation suggests that CASK could bind
to rabphilin3a, and therefore might target tra⁄cking of the
presynaptic vesicles to L-neurexins via the interaction between
rabphilin3a and rab3a.
CASK^L-neurexin^neuroligin^PSD-95 protein complexes
form an asymmetric intercellular junction at synapses [4,5].
At the postsynapse, the PDZ domains of PSD-95 bind directly
to the cytosolic carboxyl-terminus of the N-methyl-D-aspar-
tate receptors (NMDARs) which bind to the neurotransmitter
glutamate [5]. Our data suggest that at presynapse, CASK
might recruit rabphilin3a, and thus guide the presynaptic
vesicles to the sites at the plasma membrane that were de¢ned
by L-neurexins. Thus, the e⁄ciency of neurotransmission
might be greatly enhanced due to the high local concentration
of neurotransmitters around the synaptic cleft area where
NMDARs are located (Fig. 2).
In agreement with this model, neuroligin-induced synaptic
Fig. 2. Illustration of a possible mechanism in which synaptic
vesicles were recruited to L-neurexins via interaction between
CASK^rabphilin3a^rab3a at presynapse. PSD-95 binds to neuroli-
gins, NMDAR and K channel via its PDZ domains and binds to
GKAP, a postsynaptic protein, via its GUK domain at postsynapse.
L-Neurexin/neuroligin complexes mediate the formation of asymmet-
ric junctions at the synapse. CASK binds to L-neurexins via its
PDZ domain, and forms a tight tripartite complex with Mint-1 and
Veli-1 at the presynapse. CASK also binds rabphilin3a via its GUK
domain. Rabphilin3a attached to synaptic vesicles by binding to
rab3a, which is localized to synaptic vesicles. Thus, the described
protein^protein interactions result in alignment of synaptic vesicles
and postsynaptic receptors near synaptic axis mediated by L-neurex-
in/neuroligin association.
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vesicle clusters were observed at the presynaptic terminal, and
the synaptic sca¡olding protein CASK was co-localized with
presynaptic vesicle clusters in the pontine axon [26]. In the tips
of an extending axon of a developing neuron, vesicle exocy-
tosis is less e¡ective than in mature nerve termini. This was
probably due to the lack of rab3a cycling developed during
synaptogenesis, and results in e⁄cient exocytosis [27,28]. Fur-
ther studies, including the measurement of the vesicle exocy-
tosis in CASK-de¢cient cells, or synaptic plasticity in CASK-
knockout mice, will help to understand this model.
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